Tech Times on MSN
HER2-positive breast cancer trial reports 92% survival in chemo-free patients; proof pending
HER2-positive breast cancer chemotherapy can be safely omitted in about 30% of patients, five-year PHERGain trial data ...
When I took a personality test for the first time in a while, the letters and type names were different from the previous ...
When you create a template to track numbers, you start wanting to add formulas or turn it into a list. You can even have AI ...
Medical Device Network on MSN
ESMO26: Wider use of breast cancer gene test could save NHS £4m annually
Veracyte’s Prosigna is used to determine which breast cancer patients can be safely treated without the need for chemotherapy ...
Friendly A positive Widal result does not reliably confirm typhoid because antibodies can reflect previous exposure or ...
NeoCOAST-2 trial finds early ctDNA clearance in blood tests linked to improved lung cancer outcomes, potentially guiding ...
Friendly A weak neutrophil response is not always chronic granulomatous disease. The fluorescence pattern, healthy control, ...
Parents, schools and farmers are being asked whether Wales should establish a replacement school milk scheme from April 2027 ...
The Advocate highlights social inequality through original stories and opinions, and content generated by fellow NNPA and ...
A laboratory study found that raising the caloric density of a powdered enteral formula increased viscosity, shifted IDDSI ...
The final analysis of the phase III PEARLS/KEYNOTE-091 trial has confirmed a persistent disease-free survival (DFS) advantage ...
Simulations and a prototype support feedback-free resource scheduling across multiple base stations in a fully decoupled radio access network studied as a possible 6G architecture.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results